Medical Health Cluster


Vaccine Spheres of Influence Tracker

Four months after the first coronavirus vaccination campaigns began, many people—especially those living in low- and middle-income countries—are still wondering when their turn to get a shot will come and which vaccine they will receive. Based on government websites and statements, publications or contracts by vaccine manufacturers, and major local […]

Read More

AstraZeneca COVID-19 Vaccine Has 79% Efficacy

AstraZeneca’s two-dose adenovirus-vectored vaccine (AZD1222) had 79% efficacy in preventing symptomatic COVID-19 among adults in the U.S., Peru, and Chile, according to interim phase 3 trial results. The company expects to request emergency use authorization in the U.S. in the coming weeks. Researchers randomized over 32,000 adults at increased risk […]

Read More